Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure

被引:27
|
作者
Samouilidou, E
Grapsa, E
机构
[1] Alexandra Hosp, Biochem Dept, GR-11528 Athens, Greece
[2] Alexandra Hosp, Renal Unit, GR-11528 Athens, Greece
关键词
hemodialysis; peritoneal dialysis; total antioxidant capacity; malonaldehyde; 4-hydroxyalkenals;
D O I
10.1159/000070691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysis is associated with an impairment of antioxidant defense and an overproduction of oxidative stress markers. This study focuses on the comparison of plasma total antioxidant capacity (TAC) and lipid peroxidation products in patients on hemodialysis (HD) before and after treatment and in peritoneal dialysis (PD) patients. Plasma TAC, malonaldehyde (MDA), and 4-hydroxyalkenal concentrations were measured in 31 HD patients, in 24 PD patients, and in 17 normal controls (NC). It was found that before HD, TAC and MDA levels were higher than those in the NC (p < 0.001). After HD, these levels decreased significantly but were higher than in NC and lower than in PD patients (p < 0.001). The levels of 4-hydroxyalkenals were elevated in patients as compared with NC, but did not differ between HD and PD patients. The MDA concentrations correlated positively with the TAC in the patients. It is concluded that the oxidative status of patients on HD is similar to that of patients on PD and that the susceptibility to oxidative stress is strongly related to the levels of MDA produced in plasma. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [31] Total and high molecular weight adiponectin concentrations in plasma of patients with end-stage renal disease before and after peritoneal dialysis
    Park, Jae-Ho
    Gil, Hyo-Wook
    Yang, Jong-Oh
    Lee, Eun-Young
    Hong, Sae-Yong
    NEPHROLOGY, 2008, 13 (03) : 181 - 185
  • [32] Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis
    Wang, Wan-Ning
    Zhang, Wen-Long
    Sun, Tao
    Ma, Fu-Zhe
    Su, Sensen
    Xu, Zhong-Gao
    RENAL FAILURE, 2017, 39 (01) : 59 - 66
  • [33] Quality of sleep in patients with end-stage renal failure
    Tsaousis, Vasileios
    Dardas, Athanasios
    Tsavlis, Drosos
    Papakatsika, Sofia
    Gavriilidou, Anna
    Konstantinidou, Polyanthi
    Anestakis, Doxakis
    Steiropouloss, Paschalis
    PNEUMON, 2019, 32 (1-2) : 23 - 30
  • [34] The effect of hemodialysis on right ventricular functions in patients with end-stage renal failure
    Akkaya, Mehmet
    Erdogan, Ercan
    Sag, Saim
    Ari, Hasan
    Turker, Yasin
    Yilmaz, Mustafa
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (01) : 5 - 10
  • [35] Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure
    Asari, Ashwin
    Iles-Smith, Heather
    Chen, Ya-Chi
    Naderer, Odin J.
    Johnson, Mark A.
    Yuen, Geoffrey J.
    Otto, Vicky
    Dunn, John A.
    Gokal, Ram
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (06) : 738 - 744
  • [36] Effect of antioxidant vitamins on lipid profile and total antioxidant capacity in hemodialysis patients
    Montazerifar, Farzaneh
    Hashemi, Mohammad
    Karajibani, Mansour
    Dikshit, Madhurima
    RAWAL MEDICAL JOURNAL, 2010, 35 (02):
  • [37] Pulmonary hypertension in end-stage renal disease patients on dialysis and pre-dialysis patients
    Li, Yifu
    Zhang, Yan
    Wang, Jinjun
    Chen, Wenwei
    Cai, Yong
    Yang, Mei
    Li, Xiaolin
    CLINICAL AND INVESTIGATIVE MEDICINE, 2020, 43 (03): : E44 - E48
  • [38] Peritoneal Dialysis as an Option for Unplanned Dialysis Initiation in Patients with End-Stage Renal Disease and Diabetes Mellitus
    Jin, Haijiao
    Ni, Zhaohui
    Che, Xiajing
    Gu, Leyi
    Zhu, Mingli
    Yuan, Jiangzi
    Huang, Jiaying
    Gu, Aiping
    Jin, Yan
    Yan, Hao
    Wang, Qin
    Yu, Zanzhe
    Zhou, Wenyan
    Fang, Wei
    BLOOD PURIFICATION, 2019, 47 (1-3) : 52 - 57
  • [39] Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics
    Peyro-Saint-Paul, Laure
    Bechade, Clemence
    Cesbron, Alexandre
    Debruyne, Daniele
    Brionne, Marie
    Brucato, Sylvie
    Hanoy, Melanie
    Dumont, Audrey
    Briant, Anais R.
    Parienti, Jean-Jacques
    Lobbedez, Thierry
    Ficheux, Maxence
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (08) : 1918 - 1920
  • [40] Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke
    I-Kuan Wang
    Wen-Miin Liang
    Cheng-Li Lin
    Yao-Lung Liu
    Chiz-Tzung Chang
    Tzung-Hai Yen
    Chiu-Ching Huang
    Fung-Chang Sung
    International Urology and Nephrology, 2016, 48 : 139 - 147